Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OPKO Chile is the Chilean operating subsidiary of OPKO Health, focused on the importation, commercialization, and distribution of pharmaceutical products, OTC products, and medical devices in Chile. The business originated from Pharma Genexx S.A., a privately held Chilean pharmaceutical company that OPKO Health agreed to acquire in October 2009. Today, OPKO Chile appears to function primarily as a commercial-market affiliate within OPKO Health's Latin American operations rather than as a standalone R&D biotech company. Its activities are centered on marketed products and healthcare distribution across government, private, and institutional channels in Chile. Within OPKO Health, Chile is one of the company's profitable established-market operating businesses in Ibero-America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OPKO Chile.